Last reviewed · How we verify
NCT05195567
System Accuracy of a Blood Glucose Monitoring System GlucoSpark/GlucoScore
NA trial testing Glucometer Test in Diabetes Mellitus in 103 participants. Completed in 18 March 2022.
9 March 2022
Quick facts
| Lead sponsor | Institut fur Diabetes Karlsburg GmbH |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 103 |
| Start date | 17 February 2022 |
| Primary completion | 9 March 2022 |
| Estimated completion | 18 March 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Glucometer Test
- blood glucose measurement, laboratory reference device
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Institut fur Diabetes Karlsburg GmbH
Who can join
Adults 18 to 99, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO 15197
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05195567
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Glucometer Test
Trials testing the same drug.
- NCT07353125 — System Accuracy and Performance Evaluation by the User of BGM LS-9 · NA · completed
- NCT06146933 — System Accuracy of BGM GL22 · NA · completed
- NCT06037499 — System Accuracy of 14 Blood Glucose Monitoring Systems · NA · completed
- NCT06037486 — System Accuracy of BGM GL60 · NA · completed
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Institut fur Diabetes Karlsburg GmbH trials
Trials by the same sponsor.
- NCT07353125 — System Accuracy and Performance Evaluation by the User of BGM LS-9 · NA · completed
- NCT06937736 — Performance Evaluation by the User of BGM Contour Care According to ISO 15197:2015 · NA · completed
- NCT06146933 — System Accuracy of BGM GL22 · NA · completed
- NCT06037551 — System Accuracy of the Blood Glucose Monitor for Personal Use Contour Care · NA · completed
- NCT06037538 — User Evaluation of BGM JS200B · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05195567 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut fur Diabetes Karlsburg GmbH
- Last refreshed: 4 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05195567.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing